Da dets fordele ikke er bevist, fandt udvalget grund til betænkelighed ved risiciene forbundet med anvendelse i kombination med ganciclovir.
In addition, the CHMP considered there to be insufficient information on the safety of Cerepro, and, since the benefits of the medicine had not been demonstrated, that its risks, when used in combination with ganciclovir, could be of concern.